tildrakizumab,abiraterone
sun pharma
['abiraterone', 'tildrakizumab', 'abira', 'abiraterone acetate', 'prostate']
from 8am cdt at #asco23 today, simon pacey &amp; johann de bono will present results from a phase 1/2 trial of abiraterone acetate in combination with tildrakizumab in patients with #prostatecancer: #crukfunded 
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK